Archives of Medical Research
Volume 41, Issue 3 , Pages 201-206 , April 2010

Negative Association of c-fos Expression as a Favorable Prognostic Indicator in Gastric Cancer

  • Li Zhou

      Affiliations

    • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China
    • These authors contributed equally to this work.
    • ,
  • Jie-Shi Zhang

      Affiliations

    • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China
    • These authors contributed equally to this work.
    • ,
  • Jian-Chun Yu

      Affiliations

    • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China
    • Corresponding Author InformationAddress reprint requests to: Prof. Jian-Chun Yu, Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing 100730, China; Phone: 86-10-65296038; FAX: 86-10-65296038
    • ,
  • Quan-Cai Cui

      Affiliations

    • Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China
    • ,
  • Wei-Xun Zhou

      Affiliations

    • Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China
    • ,
  • Wei-Ming Kang

      Affiliations

    • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China
    • ,
  • Zhi-Qiang Ma

      Affiliations

    • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China

Received 17 December 2009 ,Accepted 12 April 2010.

References 

  1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70
  2. Shields JM, Pruitt K, McFall A, et al. Understanding Ras: “it ain't over ’til it's over”. Trends Cell Biol. 2000;10:147–154
  3. Nesbit CE, Tersak JM, Prochownik EV. Myc oncogenes and human neoplastic disease. Oncogene. 1999;18:3004–3016
  4. Chiu R, Boyle WJ, Meek J, et al. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell. 1988;54:541–552
  5. Curran T, Franza BR. Fos and Jun: the AP-1 connection. Cell. 1988;55:395–397
  6. Semba K, Kamata N, Toyoshima K, et al. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci USA. 1985;82:6497–6501
  7. Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer. 2005;41:2449–2461
  8. Volm M, Drings P, Wodrich W. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas. J Cancer Res Clin Oncol. 1993;119:507–510
  9. Bland KI, Konstadoulakis MM, Vezeridis MP, et al. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg. 1995;221:706–718
  10. Gamberi G, Benassi MS, Bohling T, et al. C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression. Oncology. 1998;55:556–563
  11. Singh A, Tong A, Ognoskie N, et al. Improved survival in patients with advanced colorectal carcinoma failing 5-fluorouracil who received irinotecan hydrochloride and have high intratumor C-fos expression. Am J Clin Oncol. 1998;21:466–469
  12. Mahner S, Baasch C, Schwarz J, et al. C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma. Br J Cancer. 2008;99:1269–1275
  13. Mitsuno Y, Maeda S, Yoshida H, et al. Helicobacter pylori activates the proto-oncogene c-fos through SRE transactivation. Biochem Biophys Res Commun. 2002;291:868–874
  14. Chang YJ, Wu MS, Lin JT, et al. Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J Immunol. 2005;175:8242–8252
  15. Wu JY, Lu H, Sun Y, et al. Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expression. Cancer Res. 2006;66:5111–5120
  16. Chen YC, Wang Y, Li JY, et al. H. pylori stimulates proliferation of gastric cancer cells through activating mitogen-activated protein kinase cascade. World J Gastroenterol. 2006;12:5972–5977
  17. Ashktorab H, Daremipouran M, Wilson M, et al. Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer. Am J Gastroenterol. 2007;102:2135–2146
  18. Takeuchi K, Motoda Y, Ito F. Role of transcription factor activator protein 1 (AP1) in epidermal growth factor-mediated protection against apoptosis induced by a DNA-damaging agent. FEBS J. 2006;273:3743–3755
  19. Shin VY, Wu WK, Chu KM, et al. Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells. Toxicol Sci. 2007;96:21–29
  20. Jin SP, Kim JH, Kim MA, et al. Prognostic significance of loss of c-fos protein in gastric carcinoma. Pathol Oncol Res. 2007;13:284–289
  21. Sobin LH, Wittekind CH. TNM Classification of Malignant Tumors. 6th ed.. New York: Wiley-Liss; 2002;pp. 65–68
  22. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  23. Carneiro F, Oliveira C, Leite M, et al. Molecular targets and biological modifiers in gastric cancer. Semin Diagn Pathol. 2008;25:274–287
  24. Donati V, Faviana P, Dell'omodarme M, et al. Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer. Hum Pathol. 2004;35:1347–1352
  25. Linderoth J, Ehinger M, Akerman M, et al. Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma. Eur J Haematol. 2007;79:146–149
  26. Chen JP, Chen L, Leek J, et al. Antisense c-myc fragments induce normal differentiation cycles in HL-60 cells. Eur J Clin Invest. 2006;36:49–57
  27. Zhang X, Zhang L, Yang H, et al. c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cells. Cancer Res. 2007;67:9425–9434
  28. Allam M, Julien N, Zacharie B, et al. Enhancement of Th1 type cytokine production and primary T cell activation by PBI-1393. Clin Immunol. 2007;125:318–327
  29. Li-Weber M, Treiber MK, Giaisi M, et al. Ultraviolet irradiation suppresses T cell activation via blocking TCR-mediated ERK and NF-kappa B signaling pathways. J Immunol. 2005;175:2132–2143
  30. Mann J, Oakley F, Johnson PW, et al. CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-kappa B, AND CBF1. J Biol Chem. 2002;277:17125–17138
  31. Fukuda K, Tsujitani S, Maeta Y, et al. The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma. Gastric Cancer. 2002;5:220–227

PII: S0188-4409(10)00100-1

doi: 10.1016/j.arcmed.2010.04.009

Archives of Medical Research
Volume 41, Issue 3 , Pages 201-206 , April 2010

Article Tools

* Image Usage & Resolution